Connect with us
https://tickernews.co/wp-content/uploads/2023/10/AmEx-Thought-Leaders.jpg

News

Musk’s $97.4 billion bid complicates OpenAI’s future plans

Elon Musk’s group bids $97.4 billion for OpenAI, complicating Sam Altman’s plans to transition it to a for-profit entity.

Published

on

Elon Musk’s group bids $97.4 billion for OpenAI, complicating Sam Altman’s plans to transition it to a for-profit entity.

In Short

Elon Musk has made a $97.4 billion unsolicited bid for the nonprofit controlling OpenAI, complicating CEO Sam Altman’s plans to turn it into a for-profit entity. This bid intensifies the conflict between Musk and Altman over OpenAI’s future direction, with Musk advocating for a return to its open-source mission.

This offer intensifies the ongoing dispute between Musk and Altman regarding the future direction of OpenAI, the organisation behind ChatGPT. Musk advocates for a return to OpenAI’s initial open-source mission, while Altman aims to invest heavily in AI infrastructure through a project named Stargate.

Musk’s offer raises concerns over the valuation of the nonprofit during its transformation, potentially granting Musk significant influence over the new for-profit structure. Support for Musk’s bid comes from his AI company xAI and various investment firms.

Musk has also filed legal complaints, claiming OpenAI has strayed from its charitable roots by creating a for-profit subsidiary and collaborating with Microsoft. In response, OpenAI rejected Musk’s criticisms, asserting that the nonprofit will be fairly compensated.

Musk’s legal team is pushing for an appraisal of the charity’s assets as the shift to a for-profit model progresses, while OpenAI has plans to finalise this transition by late 2026, following substantial funding rounds.

Despite Musk’s influence and resources, challenges remain, including opposition from rival Meta Platforms and ongoing negotiations with Microsoft and others regarding equity in the new venture. Meanwhile, OpenAI is seeking further investments amid the uncertainty created by Musk’s bid.

Continue Reading

News

U.S. strikes Houthis in Yemen for shipping attacks

U.S. military strikes in Yemen target Houthi rebels following threats to maritime security and attacks on shipping.

Published

on

U.S. military strikes in Yemen target Houthi rebels following threats to maritime security and attacks on shipping.

In Short

The U.S. has launched military strikes in Yemen against Houthi rebels following their attacks on commercial vessels, with President Trump stating the goal is to protect American shipping. The strikes have resulted in civilian casualties and are part of a broader campaign to deter aggression and ensure navigational freedom.

The U.S. has initiated military strikes in Yemen against the Houthi rebels, following their attacks on commercial vessels.

President Trump announced on his Truth Social platform that these aerial attacks aim to protect American shipping and restore navigational freedom. He stated that the Houthis will be held fully accountable for their actions.

Local sources report significant explosions in San’a, with civilian casualties reaching 31 dead and 101 injured. Yemen’s Houthi Health Ministry condemned the strikes, labelling them a war crime.

The U.S. strikes targeted Houthi leaders’ residences and their strongholds, alongside missile systems positioned along the coast. U.S. military officials have indicated that this is part of a larger campaign against the group.

The USS Harry S. Truman carrier strike group is involved in the operation, which seeks to deter aggression from Iran-backed Houthi forces and protect American interests.

Tensions escalated after the Houthis announced their intent to resume attacks on Israeli ships, claiming the lapse of ceasefire agreements.

In retaliation, Trump ordered these military actions, which aim to target Houthi leadership and missile launchers, while also signaling a warning to Iran.

Continue Reading

News

Norris wins Australian GP as Piastri’s hopes dashed

Lando Norris triumphs at the Australian Grand Prix as Oscar Piastri faces heartbreak in his home race.

Published

on

Lando Norris triumphs at the Australian Grand Prix as Oscar Piastri faces heartbreak in his home race.

In Short

Lando Norris won the 2025 Australian Grand Prix amid chaotic weather conditions, while Oscar Piastri struggled at his home race, finishing far behind expectations. Despite scoring some points, Piastri and his supporters were disappointed with his performance.

Lando Norris achieved victory at the 2025 Australian Grand Prix, marking a strong start to his season. The race featured significant chaos, largely due to rain, affecting many drivers.

Oscar Piastri, competing in his home Grand Prix, faced disappointment as his race was derailed. Piastri’s team McLaren celebrated Norris’s success while he struggled on the track.

Aussie rookie Jack Doohan’s race ended prematurely after a crash in the early laps.

Piastri was positioned close to Norris when he lost control and spun onto the grass, dropping to the back of the pack.

Despite a determined effort to regain positions, Piastri’s race did not meet the expectations of him or his supporters.

In the final moments, he managed to score some points but it was not the outcome he desired.

Fans had hoped for a better performance from their local hero, but the race results proved challenging. The event highlighted the unpredictable nature of Formula 1, especially under adverse weather conditions.

Continue Reading

News

Trump’s tariffs threaten Australia’s pharmaceutical industry prices

Trump’s tariffs may jeopardise Australia’s $1.1 billion pharmaceutical exports, risking essential medicine prices and healthcare quality.

Published

on

Trump’s tariffs may jeopardise Australia’s $1.1 billion pharmaceutical exports, risking essential medicine prices and healthcare quality.

In Short

Trump’s tariffs on steel and aluminium raise fears they could increase medicine prices in Australia, threatening its $1.1 billion pharmaceutical export industry. Prime Minister Albanese criticises the tariffs as unjustified but has ruled out retaliation, while industry experts warn against using health policies as trading leverage.

Fears have emerged that President Trump’s tariffs could adversely affect Australia’s pharmaceutical export industry, potentially raising medicine prices.

The Trump administration recently announced 25 per cent tariffs on steel and aluminium imports, sparking concern that Australia’s pharmaceutical exports, valued at approximately $1.1 billion in 2024, could face similar tariffs.

Prime Minister Anthony Albanese condemned the US tariff actions as unjustified and detrimental, indicating he would not retaliate with similar measures.

The pharmaceutical industry is a significant part of Australia’s economy and is critical to the $18 billion federal scheme that reduces essential medicine costs.

The US aims to protect its declining steel industry amidst increasing competition from Asia, particularly Canada, Brazil, and the EU.

US companies claim that Australia’s medicine pricing policies affect their earnings, raising concerns that they might push to reconsider the Pharmaceutical Benefits Scheme (PBS).

The PBS was instrumental in lowering the costs of 930 medications last year.

The Trump administration previously blamed the high costs of US medicines partly on foreign nations benefitting from US investment without contributing fairly.

Calls have been made for the Australian government to maintain a strong stance against US influence over its domestic health policies.

Albanese has ruled out retaliatory tariffs, highlighting the negative impact of trade wars on consumers.

Continue Reading

Trending Now